Portfolio company
MEDEA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bacteriophage-based antimicrobial products for customers in the human health, animal welfare, aquaculture and food protection sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
EcoPhage
This company develops bacteriophage-based biopesticides to manage bacterial diseases in crops for the agricultural industry.
PhageLab
PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.
Ancilia Bio
The company develops CRISPR-engineered bacterial therapies with viral immunity for the biopharmaceutical and healthcare sectors.
Phaxiam
The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.
Amferia
This company produces antimicrobial hydrogel wound dressings for human healthcare and veterinary markets to combat antibiotic-resistant bacterial infections.
KOA Biotech
This company develops autonomous biosensor systems for fish farms to detect waterborne pathogens and reduce mortality rates.
